Book Chapter

Psychotic Disorders

Jeffrey A Lieberman, Michael B First

The Encyclopedia of Clinical Psychology | New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2018


Funding Acknowledgements

Dr. Lieberman reports receiving grant support from Denovo, Taisho, Pfizer, Sunovion, Genentech, Alkermes, Allergan, Boehringer Ingelheim, and Eli Lilly, serving on advisory boards for Intracellular Therapeutics, Pierre Fabre, Pear Therapeutics, Psychogenics, and Clintara, and holding an issued patent (US20070154534A1) on secretin for refractory schizophrenia, licensed to Repligen; and Dr. First, receiving consulting fees from Lundbeck International Neuroscience Foundation. No other potential conflict of interest relevant to this article was reported.